Tag: Pharmaceutical costs

Only about 1 in 10 drug candidates that enter preclinical studies will ever reach market approval, a fact that underscores a critical aspect of what are the disadvantages of testing new drugs. This high failure rate reflects a complex and challenging process involving significant financial risks, potential harm to participants, and a long development timeline.

While generic antibiotics like amoxicillin can cost as little as $10-$30 for a course, the cost of treating multidrug-resistant infections with newer agents can be astronomically higher, with some treatments costing thousands of dollars for a single course. Understanding what is the most expensive antibiotic medicine requires a closer look at the evolving landscape of drug resistance and pharmaceutical pricing.

As of late 2025, pritelivir is an investigational drug and not yet commercially available, meaning there is no official market price for patients. The final amount will be determined by numerous factors upon potential regulatory approval, making the question of 'how much will pritelivir cost?' speculative at this stage.